Stockreport

ADC Therapeutics (ADCT) Reports 2025 Revenue of $73.6M With Cash Runway Into 2028 [Yahoo! Finance]

ADC Therapeutics SA Common Shares  (ADCT) 
PDF ADC Therapeutics (NYSE: ADCT ) is one of the best growth stocks to buy right now . On March 10, ADC Therapeutics reported its financial and operational results for Q4 a [Read more]